Innoplexus aus Eschborn und der Vermögensverwalter Acatis aus Frankfurt testen eine neue KI-Maschine für die Geldanlage. Der 21. März 2019 bleibt den Aktionären des Pharmakonzerns Biogen in schmerzhafter Erinnerung. Kurz vor...
Read More
Hoboken, New Jersey, September 12, 2019 – Innoplexus Inc, a subsidiary of Innoplexus AG, Frankfurt, which has developed the most comprehensive, industry-validated, AI-powered Drug Discovery and Development platform, announced today...
Read More
Hoboken, NJ, August 5, 2019 – Innoplexus Holdings, Inc., a leader in artificial intelligence (AI) solutions for the life sciences industry, has partnered with the nonprofit Cures Within Reach for...
Read More
Event Date: August 3, 2019
Where: Frankfurt am Main/ Goethe-Universität Frankfurt - Campus Westend - House of Finance...
While drug development can be incredibly lucrative, it is a very risky business. German company Innoplexus has developed a domain-specific AI prediction engine, which recently caught attention by correctly predicting...
Read More
